WallStreetZenWallStreetZen

NASDAQ: INTS
Intensity Therapeutics Inc Stock Ownership - Who owns Intensity Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Intensity Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joseph TalamoChief Financial Officer2025-12-3114,482$0.26
$3.79kBuy
John M. WesolowskiPrincipal Accounting Officer2025-12-318,918$0.26
$2.34kBuy
Joseph TalamoChief Financial Officer2025-06-3014,179$0.26
$3.70kBuy
John M. WesolowskiPrincipal Accounting Officer2025-06-3069,745$0.26
$18.20kBuy

1 of 1

INTS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INTS insiders and whales buy or sell their stock.

INTS Shareholders

What type of owners hold Intensity Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lewis H. Bender83.24%2,000,000$11.72MInsider
Sapient Capital LLC27.06%650,151$3.81MInstitution
Vanguard Group Inc27.02%649,084$3.80MInstitution
Rothschild Wealth LLC20.64%495,910$2.91MInstitution
Geode Capital Management LLC19.16%460,248$2.70MInstitution
Mesirow Financial Investment Management Inc10.45%251,000$1.47MInstitution
Legacy Advisors LLC6.39%153,447$899.20kInstitution
Creative Planning5.96%143,136$838.78kInstitution
State Street Corp5.67%136,200$798.13kInstitution
Brown Advisory Inc5.41%130,000$761.80kInstitution

1 of 3

INTS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INTS64.67%35.33%Net BuyingNet Buying
AEON6.01%93.99%Net Buying
CVKD5.85%53.11%Net SellingNet Selling
COCP0.87%99.13%Net BuyingNet Buying
CLRB8.18%79.20%Net BuyingNet Selling
View Top Biotech Stocks

Intensity Therapeutics Stock Ownership FAQ

Who owns Intensity Therapeutics?

Intensity Therapeutics (NASDAQ: INTS) is owned by 161.09% institutional shareholders, 87.99% Intensity Therapeutics insiders, and 0.00% retail investors. Lewis H. Bender is the largest individual Intensity Therapeutics shareholder, owning 2.00M shares representing 83.24% of the company. Lewis H. Bender's Intensity Therapeutics shares are currently valued at $11.72M.

If you're new to stock investing, here's how to buy Intensity Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.